Loading company…
REVA Medical develops bioresorbable polymer devices for vascular applications, including treatment of hypervascular tumors.
REVA Medical develops bioresorbable polymer technologies for vascular medical devices, including TyroSphere beads for treating hypervascular tumors. The beads are designed to degrade safely and remain visible under X-ray imaging. Based in San Diego, US, the company was founded in 1998. In December 2010, it closed a Series B funding round of USD 45.00 mn.
Funding rounds, investors and people for this company come from licensed data. A free account shows the first rows of each section; an approved contribution opens every profile in full.
Sign in